We have recently shown that the renin enhancer, a regulatory element of renin gene transcription, is important in the long-term control of basal blood pressure (BP). In this study, we examined whether the renin enhancer deficit alters the acute pressor response to emotional stress in mice.
C ardiovascular reactivity, an abrupt increase in blood pressure (BP) and heart rate (HR) in response to negative emotional stress, is thought to be a risk factor for hypertension and heart disease. [1] [2] [3] Accumulating evidence suggests that the renin-angiotensin system (RAS) is an important regulator of cardiovascular reactivity. First, the intrinsic brain RAS is implicated in the modulation of anxiety and cognitive function 4, 5 and may thus alter emotional responsiveness to aversive stimuli. Second, the brain RAS is critically involved in the central regulation of autonomic and endocrine outputs to the periphery in response to stressful stimuli. 6 -9 Third, the circulating RAS can directly modulate cardiac and vascular reactivity to sympathoadrenal activation, 10 which is a major hallmark of the stress response. In addition, circulating angiotensin II may influence the central nervous system (CNS) activity by acting at receptors localized in brain circumventricular sites, which lack the blood-brain barrier. 11 It also appears that, in regard to emotional stressors, the brain RAS can operate in a stimulus-specific manner. In particular, brain angiotensin II seems to be less important in the regulation of cardiovascular arousal caused by appetitive stimuli, such as the presentation and eating of palatable food. 9 Thus, the RAS could be a potential therapeutic target for controlling excessive cardiovascular reactivity to negative stress without affecting fluctuations in BP associated with normal daily activities, sleep, and exercise.
Renin is the rate-limiting enzyme of the RAS. The primary source of circulating renin is the renal juxtaglomerular cells, where its synthesis and secretion are tightly regulated by multiple mechanisms. 12 We have shown that the targeted deletion of the renin (Ren-1c) enhancer, which is a key regulatory element of renin gene transcription in vitro, 13 reduced renin expression and decreased BP and gross locomotor activity in mice.
14 Similarly, Zhoux and colleagues 15 have demonstrated recently that enhancer deletion decreased mRNA levels of a human renin transgene by 3-to 10-fold in mice compared with constructs containing the enhancer. Importantly, in the latter study, transgenic mice with the human enhancer deleted showed much lower levels of human renin mRNA than controls, not only at rest, but also after exposure to cues that increase expression of renin. However, whether the attenuated renin expression under stimulating conditions leads to a diminished physiologic response and whether this occurs in a stimulus-dependent manner remains unknown.
In the present study, we examined the effects of renin enhancer deficit on cardiovascular reactivity to aversive and appetitive stimuli in mice. We used a telemetry BP monitoring system to avoid the restraint and tethering stress associated with recording BP using tail-cuff and catheterization. In addition, the telemetry system also enabled us to take into account the confounding influence of locomotion, which is an essential determinant of the moment-to-moment fluctuations of BP independent of emotional state. 16, 17 Given that vascular responsiveness to sympathetic stimulation is an important regulator of cardiovascular reactivity, we also examined whether the Ren-1c enhancer deficit alters the vascular contractile response to ␣-adrenoceptor stimulation with phenylephrine in vitro.
Methods

General Preparations
The experiments were performed using 5-month-old male C57BL6 (wild-type, WT, n ϭ 7) and renin-enhancer knockout (REKO, n ϭ 8) mice in accordance with the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes. Under halothane anesthesia, mice were implanted with TA11PA-C20 telemetry probes to measure BP and locomotor activity (Data Sciences International, St. Paul, MN), as described elsewhere. 18 Each mouse was then housed individually. After a 1-week recovery period, stress tests were conducted between 11:00 AM and 4:00 PM. Mice were maintained on a 12:12-h light-dark cycle (lights off at 7:00 PM) with water and food ad libitum.
Generation of REKO Mouse
This was as described recently elsewhere.
14 Measurement of Blood Pressure, Heart Rate, and Locomotor Activity During the experiment, pulsatile arterial pressure and gross locomotor activity were monitored continuously, and were sampled at 1000 Hz using a 12-bit, 16-channel analog-to-digital data acquisition card (8024E, National Instruments, Austin, TX), and the beat-to-beat mean arterial pressure (MAP) and HR were detected on-line and analyzed using a program written in Labview. 19 
Emotional Stress and Feeding Tests
The restraint test consisted of placing a mouse in a Plexiglas restrainer for 5 min (Harvard Apparatus, South Natick, MA; length 135 mm, diameter 50 mm) with a sliding back plate to confine the mouse without applying physical pressure. Shaker stress consisted of placing a mouse home cage on a shaker for 5 min at a frequency of 100 rotations/min.
Feeding was initiated by placing a piece of almond (ϳ0.5 g) in the mouse home cage. The duration of eating was used as an inverse index of intensity of eating. 9 The shaker, restraint, and feeding were followed in the same order and were separated by 1-to 1.5-hour recovery periods. In preliminary studies, in which the order of these tests was randomized, we found no carry-over influences on stress reactivity from the preceding tests. To test the reproducibility of stress responses all tests were repeated on the following day. Because there was no difference in cardiovascular responses to the same stressor on experimental days 1 and 2, the data were pooled for subsequent analysis.
Cardiovascular Reactivity to Locomotor Activity
To calculate the reactivity index, average MAP, HR, and locomotor activity values expressed as arbitrary units (AU), were calculated during 30-sec intervals, and the activity score was logarithmically transformed to correct for positive skew. 14, 16, 17 For each mouse, least-squares regression slopes for the relationships between MAP and activity, and HR and activity, were calculated during 15-min periods (which included 5-min control, stress, and recovery periods of 10 data points for each period) using GraphPad Prism (GraphPad Software, San Diego, CA).
Measurement of Tension Responses in Aortic Rings
Animals were killed under pentobarbitone anesthesia (100 mg/kg intraperitoneally). Proximal descending thoracic aortas were isolated from REKO and WT mice (n ϭ 6 for both groups). Aortic rings tension was measured in ex vivo organ chamber baths, as described previously. 20 Full concentration-contractile curves were obtained to phenylephrine (0.1 nmol to 100 mol/L). Functional integrity of the endothelium was confirmed by determining the relax-ation response to acetylcholine (0.1 nmol to 100 mol/L) in tissues preconstricted with phenylephrine (10 mol/L). Isometric contraction induced by a submaximal concentration of angiotensin II (1 mol/L), which was selected on the basis of preliminary experiments, was also determined. Only one compound was tested on any one ring from any one animal examined. Phenylephrine, angiotensin II, and acetylcholine were purchased from Sigma Chemical Co. (Australia).
Statistical Analysis
All values are expressed as mean Ϯ SEM. Data were analyzed by two-way ANOVA to determine the effects of the Ren-1c enhancer deficit and stress on cardiovascular parameters and locomotion. The relationships between cardiovascular reactivity and physical activity (regression slopes) were compared by analysis of covariance (ANCOVA) using GraphPad Prism. Concentration-response curves were analyzed individually for the estimation of the negative logarithm of the concentration required to produce 50% of the maximal response (EC 50 ) and E max values (g/mm 2 ) for the tension responses in aortic rings. Statistical significance was set at a value of P Ͻ .05.
Results
Resting Cardiovascular Parameters
Before the shaker, restraint, and feeding tests, resting cardiovascular parameters and locomotor activity were not significantly different within groups (Table 1) ; therefore, these parameters were pooled for subsequent analysis. Prestress levels of MAP in REKO mice were lower by 8 Ϯ 2 mm Hg (P ϭ .02) than in WT mice, whereas basal HR and locomotor activity were not different between groups (Table 1) .
Shaker Stress
Shaker stress elicited prompt pressor (ϩ26 Ϯ 2 mm Hg) and tachycardic (ϩ156 Ϯ 25 beats/min) responses as well as a locomotor activation in WT mice (Fig. 1) . The pressor response was lower in REKO mice (ϩ16 Ϯ 3 mm Hg; P ϭ .03). Given a difference in basal MAP values between REKO and WT mice, the MAP reactivity (baseline corrected) to shaker stress was also calculated. The relative increase in MAP in response to shaker stress was also significantly lower in REKO mice (ϩ17% Ϯ 3%) com- pared with WT animals (ϩ26% Ϯ 2%, P ϭ .05). The stress-induced tachycardia was similar between the strains (Fig. 1) . However, the stress-induced locomotor activation was reduced in REKO mice by 64% Ϯ 11% (P ϭ .02) compared with WT mice. There was a significant correlation between MAP and locomotion in both REKO mice (r ϭ 0.46, P Ͻ .001) and WT animals (r ϭ 0.33, P Ͻ .001) during the test. The REKO mice tended to have a lower responsiveness of MAP to locomotor activity (2.9 Ϯ 0.5 mm Hg/log 10 AU) than WT animals (4.2 Ϯ 0.5 mm Hg/log 10 AU) during the test (P ϭ .066; Fig. 1) . Likewise, the HR reactivity to a given unit change in locomotor activity was lower in REKO mice (20.4 Ϯ 3.8 beats/min/log 10 AU) than that in WT animals (31.3 Ϯ 3.1 beats/min/log 10 AU, P ϭ .027).
Restraint Stress
Restraint stress caused rapid and sustained pressor (ϩ27 Ϯ 1 mm Hg) and tachycardic (ϩ219 Ϯ 9 beats/min) responses in WT mice (Fig. 2) . There was also a transient increase in locomotor activity (ϩ196 Ϯ 48 AU), as animals typically tried to escape from the restrainer. The pressor response to stress was attenuated in REKO mice (ϩ21 Ϯ 2 mm Hg, P ϭ .05) compared with WT mice. The MAP reactivity (baseline corrected) to shaker stress tended to be lower in REKO (ϩ22% Ϯ 3%) than WT mice (ϩ27% Ϯ 1%), although this did not reach statistical significance. The tachycardic and locomotor responses to restraint stress were similar between WT and REKO mice (Fig. 2) . Nonetheless, during the recovery period, locomotor activity increased in both strains, and this increase was attenuated by 43% Ϯ 10% (P ϭ .03) in REKO mice compared with WT animals (Fig. 2) .
There was a significant correlation between MAP and locomotion in both WT mice (r ϭ 0.47, P Ͻ .0001) and REKO mice (r ϭ 0.50, P Ͻ .0001) during the test (Fig. 2) . The responsiveness of MAP to locomotor activity was, however, similar between REKO (5.5 Ϯ 0.6 mm Hg/ log 10 AU) and WT animals (5.7 Ϯ 0.7 mm Hg/log 10 AU). Likewise, there were significant correlations between HR and locomotion in both REKO (51.9 Ϯ 4.6 beats/min/ log 10 AU, r ϭ 0.50, P Ͻ .0001) and WT mice (45.2 Ϯ 3.1 beats/min/log 10 AU, r ϭ 0.59, P Ͻ .0001), slopes of which were similar between groups.
Feeding
The presentation and eating of palatable food (almond) elicited prompt pressor and tachycardic responses (ϩ19 Ϯ 2 mm Hg and ϩ174 Ϯ 21 beats/min, respectively) in WT mice (Fig. 3 ). These responses were not different from those observed in REKO mice (ϩ19 Ϯ 2 mm Hg and ϩ147 Ϯ 17 beats/min, respectively). The duration of eating bouts was similar between REKO and WT mice (8.2 Ϯ 0.9 min and 8.5 Ϯ 0.8 min, respectively). There was no correlation between MAP and locomotion in either REKO (r ϭ 0.09, P ϭ not significant [NS]) or WT mice (r ϭ 0.08, P ϭ NS) during the feeding test (Fig. 3) .
Responses to Phenylephrine, Angiotensin II, and Acetylcholine in Aortic Rings
Phenylephrine evoked concentration-dependent increases in tension in both strains, with potency (log molar EC 50 ) being similar in REKO and WT animals (Ϫ6.76 Ϯ 0.13 and Ϫ6.67 Ϯ 0.05, respectively; Fig. 4) . However, the maximal contraction (E max ) to phenylephrine in the aortic rings from REKO mice was attenuated by 34% Ϯ 4% (n ϭ 6, P ϭ .03) in comparison with WT animals (n ϭ 6). Conversely, the contractile response to angiotensin II (1 mol/L) was similar in the aortic rings from REKO and WT animals (0.044 Ϯ 0.010 g and 0.038 Ϯ 0.009 g, respectively; n ϭ 5 to 6; Fig. 4) . Likewise, REKO and WT mice had similar relaxation responses to acetylcholine (n ϭ 5 to 6; Fig. 4 ).
FIG. 2. (A)
The cardiovascular and locomotor response to restraint stress in REKO and WT mice. *P ϭ .05 v WT mice. Symbols and abbreviations as in Fig. 1. (B) The relationship between MAP and locomotion during the restraint test in REKO and WT mice.
Discussion
The present study indicates that germ-line deletion of the Ren-1c enhancer, which is a key element in activation of renin gene expression, 13, 14 results in significant changes in the pressor and locomotor response to emotional stress in mice. Conversely, the renin enhancer deficit has little effect on cardiovascular arousal caused by appetitive stimuli, such as presentation and eating palatable food.
We have shown previously that deletion of the Ren-1c enhancer greatly diminished renin expression in juxtaglomerular cells, and reduced 24-h BP by 9 mm Hg, without altering HR or baroreflexes in mice.
14 More recently, we also found that, in REKO mice, Ren-1c mRNA and renin levels in adrenal and submandibular glands were 5-to 10-fold lower than in WT animals, but in the brain and heart, levels were too low for satisfactory quantification (B. Morris, unpublished observations). Apart from macula densa hyperplasia in the kidney, histologic examination of all other organs showed no significant pathologic abnormalities in REKO mice.
14 Plasma renin levels tended to be slightly lower in REKO mice, although this did not reach statistical significance (unpublished observations). Conversely, the targeted deletion of any RAS gene has been shown to produce severe phenotypes, characterized by decreases in BP by ϳ30 mm Hg, renal insufficiency, and developmental abnormalities. [21] [22] [23] [24] Thus, the REKO mouse avoids severe pathologies associated with the deletion of key RAS genes. This makes it a useful tool for studying cardiovascular consequences of mild-to-moderate disruptions in renin regulation. Findings in this model could thus have clinical relevance.
In the present study, shaker and restraint stress elicited prompt and sustained pressor responses, which were attenuated in REKO mice. In the case of shaker stress, however, this attenuation could be partly ascribed to a reduction in locomotion, which is per se an essential determinant of cardiovascular arousal. 16, 17 Moreover, during shaker stress, REKO mice showed a lower pressor response to a given increase in locomotor activity. This could further attenuate the increase in BP in these animals. It is unlikely, however, that reduced cardiovascular reactivity in REKO mice was solely mediated by diminished locomotion. These animals also showed an attenuated BP response to restraint stress (eg, under conditions in which voluntary locomotion was restricted in both groups to a similar extent). Thus, it appears that reduced cardiovascular reactivity in REKO mice can directly relate to alteration in psychoemotional, autonomic, or vascular responsiveness to stressful stimuli.
There is increasing experimental and clinical evidence that the brain RAS is important in the modulation of anxiety and cognitive function. 4, 5 In particular, it has been reported that the transgenic rat strain TGR (mREN2) 27, which overexpresses renin and develops fulminant hypertension, showed a greater anxiogenic profile than control animals. 4 Thus, it is conceivable that attenuated renin expression, apart from hypotension, can be associated with decreased anxiety or emotional reactivity to aversive stimuli. Our finding that locomotor activation was reduced in REKO mice during shaker stress and, importantly, during recovery after restraint stress (eg, when the immediate threat has passed) strongly supports this possibility. This anxiolytic effect of the renin enhancer deletion can thus be one important factor contributing to the diminished BP response to aversive stimuli.
It is also plausible that reduced cardiovascular reactivity to stress in REKO mice was, at least in part, due to disrupted hypothalamic or brainstem regulation of autonomic and endocrine outputs to the periphery. Earlier pharmacologic studies showing that microinjections of angiotensin II antagonists into specific hypothalamic or brainstem regions markedly attenuated or abolished the pressor and sympathetic responses to emotional stressors in animal models 7, 9, 25 are consistent with this possibility. A third potential mechanism for reduced BP reactivity in REKO mice may relate to disrupted neurovascular transmission. It has been shown that angiotensin II may facilitate the release of noradrenaline from sympathetic fibers, decrease its neuronal reuptake, and increase vascular reactivity to noradrenaline. 10 Therefore, it is possible that RAS disruption in REKO mice may also result in attenuated noradrenergic stimulation of vessels during stress or decreased vascular responsiveness to this stimulation. Accordingly, our present data that efficacy of ␣-adrenoceptor stimulation was attenuated in aortic rings from REKO mice indicate diminished vascular reactivity to sympathetic activation in these animals. This attenuation could not be ascribed to nonspecific depression in vascular reactivity because the contractile response to angiotensin II remained unaltered. Our results differ, however, from earlier reports that angiotensinogen or angiotensin II type 1A (AT 1A ) receptor gene deficit, which produces a drastic decrease in BP in mice, does not alter the isolated carotid artery and aortic responses to ␣-adrenoceptor stimulation. 26, 27 One explanation for such complexity might be a compensatory upregulation of vascular ␣-adrenergic mechanisms in response to low BP in these animals, 28 which could counteract the inhibitory effects of RAS disruption on neurovascular transmission.
Apart from threatening events, exposure to appetitive stimuli is capable of inducing a distinct, sympathetically mediated increase in BP. 29 In particular, food presentation and feeding are normally accompanied in animals by sustained increases in BP and HR, which are of similar magnitude to those caused by aversive stimuli. 9, 29 Remarkably, in the present study, the cardiovascular response to feeding, which had a comparable magnitude to that caused by restraint or shaker stress, was not attenuated in REKO mice. Thus, in contrast to stress-induced arousal, the renin enhancer deletion did not affect cardiovascular correlates of normal feeding behavior, which is regarded as appetitive or positively motivated. 30 These results are in accord with our recent findings that angiotensin II in the dorsomedial hypothalamus (a region that is implicated as critical in the regulation of cardiovascular arousal) modulates the pressor response to negative emotional stress but not food presentation/feeding in rabbits. 9 Collectively, these data suggest that, with respect to autonomic arousal, the RAS may be primarily involved in regulating the defense response, making it an attractive therapeutic target for selective control of BP reactivity to negative emotional events.
In summary, the present results indicate that the disrupted regulation of renin synthesis caused by the Ren-1c enhancer deficit is associated with a selective reduction in pressor and locomotor responses to negative emotional stress but not in cardiovascular arousal caused by appetitive feeding behavior in mice. The reduced locomotion cannot solely explain the diminished reactivity of BP to aversive stress in REKO mice. Instead, this attenuated reactivity appears to be mediated by multiple central and peripheral mechanisms. The precise impact of disrupted renin expression on each of these additive mechanisms will require further research.
